Up-to-date announcements, stories and opinion pieces from The AAS and researchers that we fund
Top This Week
Wednesday, July 29, 2020
World’s First Good Financial Grant Practice (GFGP) Certification
Genetic diversity in Cameroon: an invisible obstacle in human genetic studies of malaria
Tomorrow belongs to the people who prepare for it today
Why Africa needs to address deafness
Exploring the adaptive capacity of fisheries in Africa
Interesting science news from across the continent
This November/December issue of the AAS Big Picture focuses on the recent partnership between AAS and WHO, processing titanium alloys and why African scientists should apply for the Africa India Mobility Fund. It also highlights the importance of open access research as well as opportunities in research.
Origin of modern humans 'traced to Botswana'
This October issue of the AAS Big Picture showcases science in Africa tracing the origins of humankind, the fastest ants in the Sahara and exciting antimicrobial discoveries. It also highlights the importance of open access research as well as opportunities in both science journalism and biomedical research.
If you have content on science in Africa, funding opportunities or events feel free to email firstname.lastname@example.org by 15 November 2019 for inclusion in the next issue of the monthly e-newsletter.
Ebola now curable after trials of drugs in DRC
In this September 2019 issue of The AAS Big Picture we showcase opportunities in both biomedical and social science research. We also highlight some amazing science in Africa on innovative solutions to health challenges. If you have content on funding opportunities, events or science in Africa feel free to email this to email@example.com for inclusion in this monthly e-newsletter.
Apply for FLAIR Fellowships
|The African Academy of Sciences and the Royal Society are accepting applications for the Future Leaders – African Independent Research (FLAIR) Fellowships until 15 May 2019. FLAIR fellowships provide the opportunity to build an independent research career in a sub-Saharan African institution and to undertake cutting-edge scientific research that will address global challenges facing developing countries.|
The voices missing from South Africa’s response to COVID-19
(courtesy: THE CONVERSATION)
Ten days after South Africa reported its first case of COVID-19 on 5 March 2020, the government moved quickly to declare a national state of disaster. Within days a National Coronavirus Command Council had been formed, travel restrictions imposed and schools closed. A national lockdown was announced on 23 March. This remains in force though restrictions are being lifted slowly.
Enhancing collaboration to strengthen Africa`s clinical trial capacity through an online platform
Without a cure or vaccine for COVID-19, it is likely the virus will continue to cause more deaths across the world. As of June 10, 2020, there are more than 1,096 COVID-19 clinical trials in the world and these numbers are changing rapidly. Only 35 (3%) are in Africa according to clinicaltrials.gov, PACTR and COVID-19 Trial Tracker. However, the African scientific community is adapting to the rapidly changing COVID-19 environment by readying themselves to conduct both drug and vaccine focused clinical trials. This has been possible in part because the number of COVID-19 cases remains low in Africa giving the community an opportunity to plan, improve processes and define new ways of doing things under COVID-19 instigated lock downs that have been implemented across the continent.
From Africa to the World: Connecting African innovators and ideas to industry
There is a disconnect between industry, angel donors, venture capitalists and research in Africa. This has resulted in few Research and Development (R&D) outputs being scaled up or commercialized and a negligible number of patents at 0.6 percent, according to the World Intellectual Property Organization. The lack of funding also compounds the challenge meaning that quite often African innovations will rarely grow beyond just being an idea or prototype in the laboratories.
The African Academy of Sciences (AAS) today announced the launch of an innovative platform for African innovators to connect with partners who can provide funding, help them scale-up and commercialize their innovations or promote their uptake in policy.
Making an impact through an innovation ecosystem to enhance Improved lives in Africa
Simon Ndoria, Programme Officer at Grand Challenges Africa (GC Africa), presents the Grand Challenges Innovation Network, a virtual network that launched today for African innovators and innovation support partners.
Innovations at the African Academy of Sciences presents the virtual network,Grand Challenges Innovation Network (GCAiN), which launched today. This is an initiative designed to encourage and facilitate co-created solutions to narrow the funding and knowledge gaps in health and development. Ultimately, it should serve the needs of the innovation ecosystem in Africa by being the go-to network for African innovators and innovation support partners.
Why the rich must urgently help poor beat coronavirus
(Courtesy: The Standard)
We need to act fast, but also ensure that help is provided as humanly and as transparently as possible
In these challenging times, the world needs more than ever to help those most vulnerable to the effects of Covid-19.
Less affluent communities in the global south and north are vulnerable to the spread of the virus as self-isolation, lockdown, self-quarantine and social distancing will be extremely challenging.
COVID-19: Vaccine is Africa research priority
[NAIROBI] Africa’s research community says vaccine development should be a priority, a regional study has found.
Africa’s distinct research needs go beyond the global COVID-19 recommendations of the World Health Organization, and controlling the pandemic in Africa requires research and development that reflects the realities of its impact on the continent, the study suggests.
According to the findings of the survey conducted by the African Academy of Sciences (AAS), Africa needs to prioritise research and development areas such as infection prevention and control, including healthcare workers’ protection, as well as epidemiological studies and clinical management.